[
  {
    "ts": "2025-12-24T01:12:45+00:00",
    "headline": "Is Johnson & Johnson’s (JNJ) Recent Rally Still Leaving the Stock Undervalued?",
    "summary": "Johnson & Johnson (JNJ) has been quietly grinding higher, with shares up sharply over the past year even after a recent pullback. Investors are now asking whether this run still leaves meaningful upside. See our latest analysis for Johnson & Johnson. Momentum still looks constructive here, with the share price up meaningfully over the past year and a strong 90 day share price return of 16.46 percent supporting a 1 year total shareholder return of 45.41 percent. If J&J’s steady climb has you...",
    "url": "https://finance.yahoo.com/news/johnson-johnson-jnj-recent-rally-011245643.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "741fa3cd-760c-3a3c-a3b3-bdf207401f01",
      "content": {
        "id": "741fa3cd-760c-3a3c-a3b3-bdf207401f01",
        "contentType": "STORY",
        "title": "Is Johnson & Johnson’s (JNJ) Recent Rally Still Leaving the Stock Undervalued?",
        "description": "",
        "summary": "Johnson & Johnson (JNJ) has been quietly grinding higher, with shares up sharply over the past year even after a recent pullback. Investors are now asking whether this run still leaves meaningful upside. See our latest analysis for Johnson & Johnson. Momentum still looks constructive here, with the share price up meaningfully over the past year and a strong 90 day share price return of 16.46 percent supporting a 1 year total shareholder return of 45.41 percent. If J&J’s steady climb has you...",
        "pubDate": "2025-12-24T01:12:45Z",
        "displayTime": "2025-12-24T01:12:45Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/4e8319e0e61499a110aef17faa48c1a7",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/VmOStVnJjLnU3xikg4stLA--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/4e8319e0e61499a110aef17faa48c1a7.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/trESudVvS0UypUeXuQ_Yww--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/4e8319e0e61499a110aef17faa48c1a7.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/johnson-johnson-jnj-recent-rally-011245643.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/johnson-johnson-jnj-recent-rally-011245643.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "JNJ"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-24T13:02:41+00:00",
    "headline": "Here’s Why Johnson & Johnson (JNJ) Surged in Q3",
    "summary": "Meridian Funds, managed by ArrowMark Partners, released its “Meridian Hedged Equity Fund” third-quarter 2025 investor letter. A copy of the letter can be downloaded here. In the quarter, the market is more focused on the tailwind of policy easing than the headwind of weakening fundamentals, resulting in substantial gains despite stagflation emerging as a key concern. […]",
    "url": "https://finance.yahoo.com/news/why-johnson-johnson-jnj-surged-130241889.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "0842a60a-2c9d-39f0-9b01-b4463b9c7809",
      "content": {
        "id": "0842a60a-2c9d-39f0-9b01-b4463b9c7809",
        "contentType": "STORY",
        "title": "Here’s Why Johnson & Johnson (JNJ) Surged in Q3",
        "description": "",
        "summary": "Meridian Funds, managed by ArrowMark Partners, released its “Meridian Hedged Equity Fund” third-quarter 2025 investor letter. A copy of the letter can be downloaded here. In the quarter, the market is more focused on the tailwind of policy easing than the headwind of weakening fundamentals, resulting in substantial gains despite stagflation emerging as a key concern. […]",
        "pubDate": "2025-12-24T13:02:41Z",
        "displayTime": "2025-12-24T13:02:41Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/bef70c0cbbe531204698d1f5bf856093",
          "originalWidth": 768,
          "originalHeight": 430,
          "caption": "BofA Sees J&J’s Premium Multiple as Justified",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/RL78I13Rg0P5xK2Pj7z1cQ--~B/aD00MzA7dz03Njg7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/bef70c0cbbe531204698d1f5bf856093.cf.webp",
              "width": 768,
              "height": 430,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/MNPYtieVgnNbIAihNZylYw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/bef70c0cbbe531204698d1f5bf856093.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/why-johnson-johnson-jnj-surged-130241889.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/why-johnson-johnson-jnj-surged-130241889.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "JNJ"
            },
            {
              "symbol": "^GSPC"
            },
            {
              "symbol": "CBOE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-24T14:49:00+00:00",
    "headline": "The Zacks Analyst Blog Highlights Invesco, Johnson & Johnson, NiSource, Bunge Global and Morgan Stanley",
    "summary": "Invesco leads Zack' list of five high-yield S&P 500 stocks, highlighting dividend strength and steady income potential for 2026.",
    "url": "https://finance.yahoo.com/news/zacks-analyst-blog-highlights-invesco-144900649.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "df617187-3df3-3fce-82ae-4f9ab511f28e",
      "content": {
        "id": "df617187-3df3-3fce-82ae-4f9ab511f28e",
        "contentType": "STORY",
        "title": "The Zacks Analyst Blog Highlights Invesco, Johnson & Johnson, NiSource, Bunge Global and Morgan Stanley",
        "description": "",
        "summary": "Invesco leads Zack' list of five high-yield S&P 500 stocks, highlighting dividend strength and steady income potential for 2026.",
        "pubDate": "2025-12-24T14:49:00Z",
        "displayTime": "2025-12-24T14:49:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/ef8ecbce3c2a377c1f290d222c17d9a8",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/DNwg_nvYvlThZlWGJ6owgw--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/ef8ecbce3c2a377c1f290d222c17d9a8.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/PQKGLLc8wi_b6SCJwPzkEw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/ef8ecbce3c2a377c1f290d222c17d9a8.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/zacks-analyst-blog-highlights-invesco-144900649.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "JNJ"
            },
            {
              "symbol": "MS"
            },
            {
              "symbol": "MS-PQ"
            },
            {
              "symbol": "IVZ"
            },
            {
              "symbol": "BG"
            },
            {
              "symbol": "NI"
            },
            {
              "symbol": "^GSPC"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-24T16:20:00+00:00",
    "headline": "PFE's Oncology & Obesity Pipeline Position It for Post-LOE Growth",
    "summary": "Pfizer faces revenue pressure from 2026-2030 LOEs but is betting on a strengthened oncology and obesity pipeline to fuel sustainable post-LOE growth.",
    "url": "https://finance.yahoo.com/news/pfes-oncology-obesity-pipeline-position-162000310.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "a89a21b0-4158-368a-8375-a69745a3275a",
      "content": {
        "id": "a89a21b0-4158-368a-8375-a69745a3275a",
        "contentType": "STORY",
        "title": "PFE's Oncology & Obesity Pipeline Position It for Post-LOE Growth",
        "description": "",
        "summary": "Pfizer faces revenue pressure from 2026-2030 LOEs but is betting on a strengthened oncology and obesity pipeline to fuel sustainable post-LOE growth.",
        "pubDate": "2025-12-24T16:20:00Z",
        "displayTime": "2025-12-24T16:20:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/59b208c03ab625710a229f805a232093",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/w5T7o1LHfvUowVKdWOi4Rg--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/59b208c03ab625710a229f805a232093.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/3L0ANckA9Qf5lXTiNAgdWw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/59b208c03ab625710a229f805a232093.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/pfes-oncology-obesity-pipeline-position-162000310.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/pfes-oncology-obesity-pipeline-position-162000310.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PFE"
            },
            {
              "symbol": "JNJ"
            },
            {
              "symbol": "MRK"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]